Son güncelleme :
19/11/2024
Araştırma Takımlar - Faculty of Medical and Health Sciences, University of Auckland   pdf  
yeni Zelanda
üniversite
Faculty of Medical and Health Sciences, University of Auckland
Auckland
Kaynaklar   Kaynaklar   (5)  
1
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment.
Meissner S, Bansal M, Donamae P, Hanning S, Svirskis D. (d.svirskis@auckland.ac.nz)
Int J Pharm Compound - 2020 - ;24,2:140-147
2
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care.
Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y. (y.gu@auckland.ac.nz)
J Oncol Pharm Practice - 2018 - ;25,4:831-840.
3
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
Svirskis D, Lin S.W, Brown H, Sangaroothong A, Wang Z, Xu H, Dean R, Vareed P, Jensen M, Wu Z. (z.wu@auckland.ac.nz)
Int J Pharm Compound - 2018 - ;22,2:164-171
4
An investigation into the stability and sterility of citric acid solutions used for cough reflex testing.
Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D. (d.svirskis@auckland.ac.nz)
Dysphagia - 2014 -
5
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding.
Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S. ()
Int J Pharm Compound - 2009 - ; 13, 3: 250-253.

Listeler   moleküller okudu   (6)  
Çeşitli Aerosol Citric acid
kanser ilaç Enjeksiyon Doxorubicin hydrochloride
kanser ilaç Enjeksiyon Etoposide phosphate
Hormon Oral solüsyon / oral çözelti Levothyroxine
Proton pompası inhibitörü Oral solüsyon / oral çözelti Omeprazole sodium
kanser ilaç Enjeksiyon Vincristine sulfate

  Mentions Légales